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Abstract 
Background:  The Strategies to Reduce Injuries and Develop Confidence in Elders (STRIDE) 
Study is testing the effectiveness of a multifactorial intervention to prevent serious fall injuries. 
Objectives:  To describe procedures that were implemented to optimize participant retention; 
report retention yields by age, sex, clinical site, and follow-up time; provide reasons for study 
withdrawals; and highlight the successes and lessons learned from the STRIDE retention efforts.  
Design:  Pragmatic cluster randomized trial. 
Setting:  86 primary care practices within 10 US health care systems. 
Participants:  5,451 community-living persons, 70+ years, at high risk for serious fall injuries. 
Measurements:  Study outcomes were collected every 4 months by a central call center.  
Reconsent was required to extend follow-up beyond the originally planned 36 months. 
Results:  Over a median [IQR] follow-up of 3.2 [2.8–3.7] years, 439 (8.1%) participants died 
and 600 (11.0%) withdrew their consent or did not reconsent to extend follow-up beyond 36 
months, yielding rates (per 100 person-years) of deaths and withdrawals of 2.6 and 3.6.  The 
withdrawal rate increased with advancing age, was comparable for men and women, and did not 
differ much by clinical site.  The most common reasons for withdrawal were illness and unable 
to contact for reconsent at 36 months.  Completion of the follow-up interviews was greater than 
93% at each time point.  Most participants completed all (71.8%) or all but one (9.2%) of the 
follow-up interviews.  The most common reason for not completing a follow-up interview was 
unable to contact, with rates ranging from 2.8% at 40 months to 4.6% at 20 months.   
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Conclusions:  Completion of the thrice-yearly follow-up interviews in STRIDE was high, and 
retention of participants over 44 months exceeded the original projections.  The procedures used 
in STRIDE, together with lessons learned, should assist other investigators who are planning or 
conducting large pragmatic trials of vulnerable older persons. 
 
Key words:  older persons; retention; pragmatic trials 
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 Retention of participants in clinical trials is important for ensuring that the results are 
adequately powered, valid and generalizable.1-3  A trial with higher than expected losses to 
follow up might be under-powered to detect a treatment effect even if its recruitment target was 
met.1  In addition, poor retention of participants can reduce the internal validity of a trial when 
losses to follow-up differ significantly by treatment group.2  Finally, because participants who 
drop out of a study usually differ from those who are retained,3 findings from a trial may not be 
generalizable to the target population when retention is poor. 
 Nonetheless, strategies to optimize retention in clinical trials have generally received less 
attention than those focused on recruitment.  Even reports about recruitment and retention have 
focused considerably more attention on the former issue than the latter.4-7  Relatively few prior 
trials have focused on strategies to enhance retention of older persons who are frail or at risk of 
falls.8  Retention is more challenging in this population because of the high prevalence of 
impairments in mobility, cognition, hearing, and vision, and because concurrent health problems 
often worsen over time, leading to hospitalization and subsequent changes in living situation.   
 We recently completed follow-up for the Strategies to Reduce Injuries and Develop 
Confidence in Elders (STRIDE) Study, a large 44-month pragmatic cluster randomized trial.9   
The aim of STRIDE is to determine the effectiveness of an evidence-based, patient-centered 
multifactorial intervention to prevent serious fall injuries.  The current report describes the 
procedures that allowed us to optimize retention over a follow-up period ranging from 24 to 44 
months.  We report retention yields by age, sex, clinical site, and follow-up time, provide reasons 
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for study withdrawals, and highlight the successes and lessons learned from the STRIDE 
retention efforts.   
   




 The study design, screening, recruitment and baseline characteristics for STRIDE have been 
previously described.9, 10  Over the course of 20 months, 5,451 community-living persons, 70 
years or older, who were at high risk for serious fall injuries, were recruited from 86 primary 
care practices within 10 diverse healthcare systems (i.e. clinical sites) across the US.10  
Recruitment, enrollment, and follow-up assessments were completed over the phone by the Yale 
Recruitment and Assessment Center (RAC).  All study materials and interviews were available 
in English and Spanish.  The inclusion and exclusion criteria are provided in Supplementary 
Table S1. 
 Data on falls, serious fall injuries, and other fall injuries were collected every 4 months using 
a structured telephone interview that also ascertained hospital admissions, emergency department 
(ED) visits, and other health care utilization.  To facilitate recall, participants were provided 
monthly calendars to record their falls and injuries.  Details about the ascertainment and 
adjudication of serious fall injuries are provided elsewhere.11  Among a random subsample of 
714 participants, who were enrolled earlier in the trial before the age criterion was lowered from 
75 to 70 years,10 information was also collected at baseline, 12 months and 24 months on a set of 
secondary well-being outcomes,9 including concern about falling,12 anxiety and depressive 
symptoms,13 and physical function and disability.14  The original sample size estimates assumed 
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3% annual loss-to-follow-up in the absence of a serious fall injury or death and 7% annual death 
rate in the absence of a serious fall injury.9 
 Study procedures were developed in partnership with a diverse set of patient stakeholders,9 
who also reviewed relevant materials, such as participant letters, interviewer scripts, brochures 
and newsletters, to ensure clarity and readability.  To preserve blinding of RAC interviewers, 
communication with the clinical sites was conducted by unblinded RAC staff in partnership with 
Central Project Management (CPM), located at Brigham and Women’s Hospital.  Finally, 
detailed progress reports were reviewed during monthly conference calls by the Screening, 
Recruitment and Retention Committee, which included representatives from the clinical sites, 
patient stakeholders, RAC, Data Coordinating Center (DCC), and CPM. 
 
Extension of Follow-up 
 Follow-up was originally planned for up to 36 months, but after approval had been obtained 
from the Central Institutional Review Board (IRB) it was later extended to March 2019 (to 
maintain 90% power),10 providing 24 to 44 months of surveillance.  Reconsent to extend follow-
up was requested from participants at the end of the 36-month telephone interview.   
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Procedures to Optimize Retention 
Time of Enrollment 
 During the informed consent process, the purpose of the trial, study requirements, and time 
commitment were clearly explained to the participant and/or surrogate.  Contact information was 
obtained for the participant, surrogate, and up to two other persons who did not live with the 
participant but would know how to reach them if RAC staff were unsuccessful.   
 
Mailed Correspondence 
 After enrollment, a packet of materials was mailed to participants by unblinded RAC staff, 
including: thank you letter; study brochure; privacy and consent information sheet; study 
assignment (intervention or usual care); initial fall calendars (5 months) with instructions to 
complete each month; STRIDE magnet with recommendation to post with calendars on the 
refrigerator; and NIA “Falls and Older Adults” sheet (Supplementary Document S1).  In 
addition, the usual care group received the CDC Stay Independent brochure 
(www.cdc.gov/steadi/pdf/stay_independent_brochure-print.pdf).    
 About two weeks prior to each thrice-yearly interview, a follow-up packet was mailed, 
including: cover letter that provided a reminder of the upcoming call, expressed appreciation, 
and encouraged continued participation in the study; and a set of 5 monthly fall calendars.  These 
mailings also included a token of appreciation every 12 months, including a magnifier, eyeglass 
cleaning cloth, and rubber jar opener, each branded with the STRIDE logo, and a periodic 
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STRIDE newsletter that included endorsements from local patients/stakeholders and clinicians 
about importance of the study. 
 
Thrice-yearly Telephone Interviews 
 The follow-up interviews were completed by carefully selected research staff at the RAC 
who were rigorously trained in retention techniques (Table 1).  Training sessions, led by the 
RAC director and two senior research staff, were held at the outset of the study.  A video on 
interviewing techniques and bias was viewed and discussed during one of the sessions.  
Interviewers were certified only after they had: (1) passed quizzes on key aspects of the protocol, 
manual of procedures, and video; and (2) satisfactorily completed three sample follow-up 
interviews.  To enhance fidelity, calls were monitored, frequently at first and subsequently on an 
as-needed basis. 
 Calls, which lasted less than 10 minutes on average, started one week before the 4-month 
target date with a 9-week window for completion.  Up to 5 calls were made, with at least one in 
the morning, afternoon, evening, and weekend.  The interviewers stated that they were calling 
from the Yale University STRIDE Study and wanted to review the participant’s fall calendar 
information.  When needed, messages were left that stated the interviewer’s name and reason for 
the call, provided the toll-free phone number, and requested a good day/time for a return call.  
Secure remote access for direct data entry was established so that interviewers could complete 
calls from home (e.g., during evenings, weekends or inclement weather). 
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 Given the large number of call assignments, i.e. up to 1800-1900 per month, interviewers had 
to work effectively as a team.  Two lead interviewers reviewed and carefully planned call 
assignments based on schedules, participant/surrogate requests, and primary language.  The field 
director established call priorities, reviewed difficult cases, and coordinated communication with 
CPM.   
 To assess the need for remedial training, the field director reviewed the frequency of call 
outcomes by interviewer ID.  Productivity and success (e.g. number of calls, number of 
completed interviews) were determined using standard time estimates and benchmarks.  
Retraining was also provided at 6-month intervals and when the call management system 
(described below) was updated. 
 
Systems Support 
 Data collection was completed using REDCap (http://project-REDCap.org), a secure, 
HIPAA-compliant web-based application.15  To enhance workflow, the DCC developed a 
customized “plug-in”, called the Follow-up Interview Manager (FIM).  The FIM allowed the 
field director to manage interviewer case load and provided interviewers with helpful 
information about their open interviews, including: target date, contact information, detailed 
summary of prior contacts, log of notes, and designated surrogate.  Open interviews were flagged 
if they were beyond the 9-week window and could be easily sorted by interviewer, target date, 
type of call (e.g. Month 16), number of calls, last call, and date of participant call back.  
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Communication was enhanced through a cumulative log of notes entered by interviewers and 
operations staff (i.e., best times to call, assignment to a specific interviewer, etc.).   
  To effectively manage all aspects of the field operations, a custom software program, called 
the “Tracker”, was also developed.  The notes field in the Tracker, which was linked to the notes 
in the FIM, facilitated communication of requests between interviewers and other study staff 
(e.g., mail follow-up packet to alternate address during specific months), and allowed 
interviewers to record relevant participant-specific information, such as birthday, vacation plans, 
and sick family members, that could help personalize follow-up calls.  An integrated data system 
permitted contact information to be easily updated from different sources, increasing the 
likelihood of successful call attempts.   
    
Mechanisms for Participants to Contact Study Team 
 The primary mechanism for participants (or surrogates) to contact the RAC was a toll-free 
number.  Voicemail messages were checked twice daily (morning and afternoon) with the aim of 
returning calls within 24 hours.  Clear and precise voicemail transcription by unblinded staff 
facilitated triage of messages to interviewers, data managers, field director, CPM, or clinical site, 
as appropriate.  For example, calls about the intervention were forwarded to the clinical site.  
Although used less commonly, email and postal mail provided alternative mechanisms of contact 
with the RAC. 
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Activities at Clinical Sites 
 To enhance the visibility of STRIDE across the participating practices, research staff at the 
clinical sites provided study updates through local newsletters, in-service presentations and other 
forums.  The content of these updates was informed through discussions with the Local and 
National Patients’ and Stakeholders’ Committees. 
 
Special Circumstances 
Participant Death  
 Deaths were ascertained by the RAC through multiple mechanisms, including a follow-up 
interview, an email or phone message from a family member or surrogate, a note of deceased 
from the post office, an online obituary, a serious adverse event (SAE) report from the clinical 
site, or a note in REDCap based on site-specific safety and outcomes surveillance.9, 11  A final 
interview was attempted with a surrogate at least four weeks after the death.  If unsuccessful 
after two attempts, a condolence letter, written in close collaboration with the patient 
stakeholders, was sent, asking the surrogate if s/he would be willing to call the toll-free number 
to arrange a time for the final interview.  Interviewers were prepared to describe the study to 
surrogates who might not have known about the participant’s involvement. 
 
Reluctant Participant 
 When participants expressed an interest in withdrawing from the study, interviewers were 
trained to offer options that might be considered less “burdensome”, such as eliminating the use 
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of fall calendars and reducing the frequency of follow-up interviews.  If participants declined 
less intensive follow-up, they were asked for permission to continue tracking their healthcare 
utilization and medical records, i.e. partial withdrawal.9  Continued tracking was important 
because the adjudication protocol required that a self-reported serious fall injury be confirmed by 
another data source,11 and the Central IRB did not allow us to access healthcare utilization or 
medical records after a participant withdrawal, even if the fall injury occurred prior to the date of 
withdrawal. 
 If the interviewers learned of a withdrawal from a phone or email message and were unable 
to reach the participant by phone, a personalized letter was sent offering the option of partial 
withdrawal.  Whenever possible, the reason for withdrawal was ascertained. 
 
Unable to Locate Participant 
 When participants or surrogates could not be reached by phone after 3-4 attempts, 
interviewers called the additional contacts provided by the participant to inquire about a change 
in status (e.g., move or illness), or to complete the interview when appropriate.  When these 
efforts were not successful, unblinded RAC staff asked the clinical site for updated contact 
information or report of death.  If needed, a personalized letter was sent to participants indicating 
that the RAC was trying to reach them and requesting that they provide the best phone number 
and time to call via the toll-free number or email.  For completeness, the RAC also reviewed 
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“undeliverable” letters for new addresses from the Post Office and checked electronic obituaries, 
Whitepages, and reverse phone lookup. 
 
Extending Follow-up Beyond 36 Months 
 Upon completion of the 36-month interview, participants were thanked for participating in 
the STRIDE Study and were asked for permission, i.e. reconsented, to extend follow-up through 
the end of March 2019.  Participants were informed that their continued follow-up would allow 
us to better accomplish the goals of the study.  Interviewers were trained to share the value of 
having participants continue their involvement in the study without exerting pressure.  
Participants who declined to complete any additional interviews were asked for permission to 
continue tracking their healthcare utilization and medical records through the end of March 2019. 
 
Statistical Analyses 
 The percentages of participants who were lost to follow-up from deaths and withdrawals 
(partial or full) through March 2019 were calculated by age, sex, and clinical site.  To account 
for differences in the duration of follow-up, values were also calculated as rates per 100 person-
years.  These analyses were repeated for the subsample (714 participants), the remaining 4,737 
participants, and the subset of 1,214 participants who were enrolled contemporaneously with the 
subsample, although these results were not stratified by clinical site because of small numbers.  
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Finally, completion of the follow-up interviews was calculated over time; and reasons for 
withdrawals (partial and full) were categorized.   
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RESULTS  
 Over a median [IQR] follow-up of 3.2 [2.8–3.7] years, 439 (8.1%) participants died and 600 
(11.0%) withdrew consent or did not reconsent to extend follow-up beyond 36 months, yielding 
rates (per 100 person-years) of deaths and withdrawals of 2.6 and 3.6.  Less than 5% of the 
withdrawals (29/600) occurred after completion of the 36-month follow-up interview.  Table 2 
provides results according to age, sex, and clinical site.  As expected, mortality increased with 
advancing age and was higher for men than women.  Although withdrawals also increased with 
advancing age, with rates (per 100 person-years) ranging from 1.7 for participants 70-74 years to 
5.8 for those 85 years or older, they differed little by sex.  Losses to follow-up did not differ 
appreciably by clinical site, with mortality rates ranging from 1.8 for Partners Healthcare to 3.9 
for Reliant Medical Group and withdrawal rates ranging from 2.5 for Johns Hopkins Medicine to 
4.6 for University of Pittsburgh Medical Center.  As shown in Supplementary Table S2, 
mortality and withdrawal rates were higher for the random subsample of participants, and these 
differences were observed for all but two of the age- and sex-specific subgroups.  However, 
among participants who were recruited contemporaneously, these differences were generally 
diminished for mortality and were largely eliminated for withdrawals (Supplementary Table 
S3). 
 As shown in Figure 1, the completion rate for the follow-up interviews, including surrogate 
death interviews, was greater than 93% at each time point.  Most participants completed all 
(71.8%) or all but one (9.2%) of the follow-up interviews.  At each time point, the most common 
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reason for not completing a follow-up interview was unable to contact (with or without loss to 
follow-up), with rates ranging from 2.8% at 40 months to 4.6% at 20 months.  Although the rate 
of partial withdrawal was less than 0.7% at each interview other than 40 months, the absolute 
number over time was not insubstantial at 170.   
 The reasons for study withdrawals are provided in Table 3.  Overall, the most common 
reasons for study withdrawal were illness, unable to contact for reconsent at 36 months, study 
not useful, too busy, and no longer interested, although 13.8% of participants provided more than 
one reason.  Differences in reasons between the partial and full withdrawals were relatively 
modest except for illness, unable to contact for reconsent at 36 months, and declined to extend 
follow-up beyond 36 months.  
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DISCUSSION  
 The procedures described in the current manuscript allowed us to approximate an ambitious 
goal of limiting losses to follow-up for reasons other than death to 3% per year in the absence of 
a serious fall injury.  Over a follow-up period of 24 to 44 months, the rates of withdrawals and 
deaths per 100 person-years were 3.6 and 2.6, respectively, compared with the projected rates of 
3.0 and 7.0, indicating that retention of participants exceeded the estimates used in the original 
sample size calculations9.  Because the reported rates do not account for losses that occurred 
after a serious fall injury, the STRIDE Study should maintain its projected 90% power to detect a 
20% reduction in serious fall injuries.   
 The 21 participants who declined to extend their follow-up beyond the originally planned 36 
months were included as study withdrawals.  Many of these participants told the interviewers 
that they had fulfilled their original commitment and did not feel comfortable changing the 
agreement, highlighting the importance of establishing clear expectations at the outset of a trial.  
Another 75 participants could not be contacted for reconsent at 36 months.  Together, these two 
groups represented about 16% of the study withdrawals, making our retention rate conservative.  
Future trials might consider including language about the possibility of extending follow-up in 
the informed consent process.  Not surprisingly, the most common reason for study withdrawal 
was illness.  The majority of participants (mean age, 80 years) had multimorbidity, all were at 
increased risk for falls, and only a minority reported excellent or very good self-reported 
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health.10  Nonetheless, the observed mortality rate was less than half the projected rate, 
suggesting the possibility of a healthy enrollee effect.   
 The withdrawal rate increased as expected with advancing age, was comparable for men and 
women, and did not differ much across the ten clinical trial sites.  Because more than a third of 
the participants who withdrew from the study permitted continued tracking of their health care 
utilization and medical records, it will be possible to confirm their previously reported fall 
injuries.11  We found that the withdrawal rate was higher among the subsample of 714 
participants (compared with the remaining 4,737 participants) who had agreed to the expanded 
interviews at baseline, 12 months and 24 months, which usually took about 10 additional minutes 
to complete, suggesting potential trade-offs between retention and collection of additional data.  
Participants in the subsample also had higher mortality, a finding that could not be explained by 
differences in age or sex.  These subsample differences, however, were diminished or eliminated 
when comparisons were restricted to participants who were recruited contemporaneously, 
suggesting that the mix of participants may have changed over the 20-month recruitment period. 
 Given the importance of retention for optimizing the power, validity and generalizability of a 
clinical trial, we implemented a series of retention-enhancing procedures (described in Methods) 
that were based on best practices and our collective clinical trial experience.  During the trial, we 
faced a series of challenges, both expected and unexpected, that might have diminished retention.  
These challenges, along with strategies designed to optimize retention, are summarized in Table 
4.  A guiding principle was that every contact between research staff and participant contributes 
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to the likelihood that the participant will remain in the trial.  Interviewers asked about falls and 
injuries since the last completed interview, enhancing ascertainment in the setting of one or more 
missed interviews.  While face-to-face contacts may help to establish and strengthen connections 
between research staff and participants, all follow-up interviews in STRIDE were completed 
over the phone, obviating the need for vulnerable older persons to travel to an assessment center. 
 Many older persons participate in research studies out of a sense of altruism.16  For clinical 
trials such as STRIDE, participants who are assigned to an active treatment group may also 
benefit from the intervention being evaluated.  Because the blind has not yet been broken, it was 
not possible to determine whether retention differed by treatment group.  Because the interviews 
were completed by phone, our findings may not be generalizable to other modes of follow-up.  
Despite these limitations, STRIDE is one of the few trials, to our knowledge, that has rigorously 
evaluated retention of older participants, particularly those who are frail or at risk of falls.  
According to a recent systematic review17 and an earlier Cochrane review,18 only four prior 
reports have empirically evaluated retention among persons 70 years or older,19-22 and all four 
evaluated response rates to a postal questionnaire, with follow-up ranging from only 4 months21 
to 2 years.20   
 In summary, completion of the thrice-yearly follow-up interviews in STRIDE was high, and 
retention of participants over 44 months exceeded the original projections.  The procedures used 
in STRIDE, together with lessons learned, should assist other investigators who are planning or 
conducting large pragmatic trials of vulnerable older persons. 
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Figure 1.  Completion of the follow-up interviews over time.  Rates are based on the number of 
non-decedents from the prior interview, which is provided at the top of each bar.  A diminishing 
number of participants who were enrolled later in the study were scheduled for follow-up 
interviews beyond 24 months.  As described in the Methods, participants had to be reconsented 
at 36 months.  A surrogate death interview was completed for 299 (76.7%) of the 390 decedents 
who had not completed the final follow-up interview, been lost to follow-up, or withdrawn 
partially from the study.  The designation, “Unable to contact, lost to follow-up”, was made 
retrospectively at the end of the study. 
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Month of Follow-up Interview
Completed interview
Completed surrogate death interview
Unable to contact, not lost to follow-up
Refused, not withdrawn
Full withdrawal
Did not complete surrogate death interview
Unable to contact, lost to follow-up
Partial withdrawal
5451 5239 5104 4943 4833 4713 3554 2374 1335 426 7
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Table 1. Characteristics and Training of STRIDE Interviewers 
Characteristics 
 Mature, experienced in geriatrics 
 Pleasant, persistent, good communication skills 
 Successful experience with study retention  
 Understands importance of study  
 Available to work evening and weekend hours 
Training 
 Study protocol and manual of procedures 
 Probing and minimizing bias 
 Active listening skills  
 “Customer” care relations 
 Motivational interviewing 
 Handling difficult circumstances, e.g. illnesses, deaths, etc.  
 Performance expectations 
 Identifying need for surrogate because of impairments in 
cognition/hearing 
 Introducing study to new surrogates or other “gatekeepers” 
unfamiliar with STRIDE 
 Use of standardized abbreviations in note fields 
 Use of nouns, rather than pronouns in note fields: “she” 
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Table 2.  Losses to Follow-up from Deaths and Study Withdrawals by Age, Sex and Clinical Site  
 Enrolled Died, not Withdrawn Withdrawna 
Characteristics N n percent rateb n percent rateb 
Overall 5,451 439 8.1 2.8 600 11.0 3.6 
Age, y        
70-74 1,037 31 3.0 1.1 49 4.7 1.7 
75-79 1,857 103 5.5 1.7 192 10.3 3.3 
80-84 1,344 114 8.5 2.7 154 11.5 3.6 
85 or older 1,213 191 15.7 5.4 205 16.9 5.8 
Sex        
Men 2,070 226 10.9 3.6 220 10.6 3.5 
Women 3,379 213 6.3 2.1 380 11.2 3.7 
Clinical Site        
Essentia Health 462 47 10.2 3.5 60 13.0 4.4 
Healthcare Partners 419 36 8.6 2.8 51 12.2 3.9 
Johns Hopkins Medicine 620 45 7.3 2.4 47 7.6 2.5 
Mercy Health Network, U Iowa 369 31 8.4 2.8 41 11.1 3.6 
Michigan Medicine, U Michigan 549 49 8.9 2.8 54 9.8 3.1 
Mount Sinai Health System 504 33 6.5 2.2 44 8.7 2.9 
Partners Healthcare 735 42 5.7 1.8 79 10.7 3.5 
Reliant Medical Group 602 74 12.3 3.9 85 14.1 4.5 
U Pittsburgh Medical Center 650 47 7.2 2.4 91 14.0 4.6 
U Texas Medical Branch 541 35 6.5 2.2 48 8.9 3.0 
a Includes partial and full withdrawals.  29 (4.8%) of the withdrawals occurred after completion of the  
36-month follow-up interview, but before the end of the extended follow-up on March 31, 2019.   
b Per 100 person-years of follow-up 
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 n (%) 
Illness 101 (16.8) 55 (25.6) 46 (11.9) 
Unable to contact for reconsent at 36 months 75 (12.5) 0 75 (19.5) 
Study not useful 50 (8.3) 23 (10.7) 27 (7.0) 
Too busy 42 (7.0) 12 (5.6) 30 (7.8) 
No longer interested 42 (7.0) 15 (7.0) 27 (7.0) 
Declined to extend follow-up beyond 36 months 21 (3.5) 0 21 (5.5) 
Moved out of area or to facility 15 (2.5) 12 (5.6) 3 (0.8) 
Did not understand what study involved 12 (2.0) 4 (1.9) 8 (2.1) 
Participant unable and surrogate refused 12 (2.0) 6 (2.8) 6 (1.6) 
No longer receiving primary care at assigned practice 8 (1.3) 1 (0.5) 7 (1.8) 
Other 107 (17.8) 46 (21.4) 61 (15.8) 
Multiple reasons 81 (13.5) 28 (13.0) 53 (13.8) 
No reason given 34 (5.7) 13 (6.0) 21 (5.5) 
a Participant declined to complete any additional follow-up interviews, but permitted continued 
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Table 4.  Challenges and Strategies to Optimize Retention in STRIDE Study 
Challenges Strategies 
Caller ID Have same interviewer with same number call participant over time 
Era of robocalls Leave clear and distinct message(s) on voice mail, while holding on 
phone to give participant time to answer 
Participants have busy schedules Follow-up Interview Manager provided days/times when prior calls 
were completed, tracked number and days/times of attempted calls, 
and flagged interviews that were overdue. 
Large volume of calls Effective communication among interviewers 
No face-to-face contact between 
interviewers and participants 
Ensure that all forms of communication with participants are clear 
and consistent 
Patient stakeholders reviewed all written correspondence for 
readability. 
Prior to each follow-up interview, reminder letters were mailed with 
the next set of fall calendars.  
Contact information is incomplete 
or not current 
Call alternative contact(s) 
Unblinded RAC staff request current contact information from clinical 
site. 
Reluctant participant Be respectful but persistent 
Listen carefully 
Offer to call back on another day and/or time 
Avoid getting to “no” by offering to skip current interview and trying 
again in 4 months 
Discuss difficult cases with field director, leading to customized 
approach  
Participant appears to be 
confused 
Reach out to alternative contact and ask him/her to serve as 
surrogate 
Unexpected events Interviewers were trained to be prepared for uncommon events, e.g. 
recent death or illness of a participant or loved one. 
Adjust call schedules due to extraordinary circumstances at a clinical 
site, e.g. hurricane, wildfires, school shooting 
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Work with clinical sites and CPM to modify communication with 
participants who evidence heightened sensitivity 
 Allow more time to complete interview 
Abbreviations: CPM, Central Project Management; RAC, Recruitment and Assessment Center 
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